Levels of cytokines in extended purulent peritonitis and methods of immunocorrection

Keywords: extended purulent peritonitis; anti-inflammatory cytokines; cytokinotherapy.


Objective. Comparative studying of the cytokines secretion dynamics in extended purulent peritonitis in postoperative period on background of the standard basic therapy and its combination with cytokinotherapy.

Materials and methods. The levels of anti-inflammatory cytokines IL-2, IL-6, IL-8 and TNF-α in the blood of 97 patients, suffering extended purulent peritonitis of various genesis and various severity degree, were determined. Depending on kind of therapy conducted, the patients were divided into two Groups: the first one - 52 patients, obtaining standard basic therapy and the second - 45 patients, to whom cytokinotherapy was prescribed additionally to standard basic therapy.

Results. In the Group II patients the levels of IL-2, IL-6, IL-8 and TNF-α were raised significantly in reactive phase in 2.1 (p=0.035), 2.4 (p=0.002), 2.0 (p=0.004) and 3.5 (p=0.001) times, accordingly; toxic - in 5.1 (p<0.001), 5.6 (p<0.001), 2.4 (p<0.001) and 6.6 (p<0.001) times, accordingly; terminal - in 8.7 (p<0.001), 8.7 (p<0.001), 4.7 (p<0.001) and 8.6 (p<0.001) times, accordingly, comparing with control. On the tenth postoperative day the concentration of proinflammatory cytokines have lowered significantly in comparison to preoperative data.

Conclusion. In all the patients, owing various degrees of the extended purulent peritonitis severity, preoperatively a statistically significant raise of concentration of proinflammatory cytokines IL-2, IL-6, IL-8 and TNF-­α, comparing with indices in healthy persons, was noted. Targeted immunocorrection, using combined cytokinotherapy on background of complex basic treatment measures, normalizes a cytokinic balance.

Author Biography

E. T. Mammadova, Azerbaijani Medical University, Baku

Mammadova Esmira Tarverdi, MD.
Chief laboratory of department of surgical diseases III.
General surgeon of Surgical clinic of Azerbaijan Medical University
Surgical clinic of Azerbaijan Medical University.
Azerbaijan Medical University.
155 Samed Vurgun Str., Baku, Azerbaijan
+994 51 923 09 23


Styazhkina SN, Ovechkina IA, Shakirova LC, Khabibullina GF. Peritonitis in modern abdominal surgery. International scientific review. 2017);(4): 98-102. Russian.

Kosinets VA. Pathogenetic aspects of complex treatment of patients with widespread purulent peritonitis. Bulletin of Vitebsk State Medical University. 2014;13(4):63-9. Russian.

Lazarev SM, Gamzatov KhA. The role of cytokines in the development and treatment of peritonitis. Bulletin of surgery named after I. I. Grekov. 2008;167(5):109-13. Russian.

Soukovatih BS, Blinkov YuYu, Frolova OG. Mechanisms of the diffuse peritonitis development. Bulletin of experimental and clinical surgery. 2012;5(2):470-8. Russian. doi: 10.18499/2070-478X-2012-5-2-470-478.

Hall JC, Heel KA, Papadimitriou JM, Platell C. The pathobiology of peritonitis. Gastroenterology. 1998 Jan;114(1):185-96. doi: 10.1016/s0016-5085(98)70646-8. PMID: 9428232.

Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, et al. Role of cytokines as a double-edged sword in sepsis. In Vivo. 2013 Nov-Dec;27(6):669-84. PMID: 24292568; PMCID: PMC4378830.

Badiu DC, Paunescu V, Aungurenci A, Pasarica D. Proinflammatory cytokines in peritonitis. J Med Life. 2011 May 15;4(2):158-62. Epub 2011 May 25. PMID: 21776298; PMCID: PMC3124274.

Chepurnyh EE, Shurygina IA, Shaulskaja ES, Shurygin MG. Role of cytokines in the pathogenesis of diffuse bacterial peritonitis. Acta Biomedica Scientifica. 2016;1(4):177-82. Russian. doi: 10.12737/23029.

Riché F, Gayat E, Collet C, Matéo J, Laisné MJ, Launay JM, et al. Local and systemic innate immune response to secondary human peritonitis. Crit Care. 2013 Sep 12;17(5):R201. doi: 10.1186/cc12895. PMID: 24028733; PMCID: PMC4057228.

Gadzhiev NJ. Immune status, cytokine profile and endogenous intoxication in patients with diffuse peritonitis. Surgery of Ukraine. 2012;4:67-75. Russian.

Hajiyev NJ, Klimova EM, Nasirov MY, Sushkov SV, Drozdov LA.

The dynamics of cytokines in patients with generalized peritonitis. Transbaikalian Medical Bulletin. 2012;(2):106-10. Russian.

Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012 Feb 17;12(3):180-90. doi: 10.1038/nri3156. PMID: 22343569.

Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013;2013:165974. doi: 10.1155/2013/165974. Epub 2013 Jun 18. PMID: 23853427; PMCID: PMC3703895.

Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014 Sep 4;6(10):a016295. doi: 10.1101/cshperspect.a016295. PMID: 25190079; PMCID: PMC4176007.

Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, et al. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis. Perit Dial Int. 1996 Jul-Aug;16(4):385-92. PMID: 8863332.

Chu WM. Tumor necrosis factor. Cancer Lett. 2013 Jan 28;328(2):222-5. doi: 10.1016/j.canlet.2012.10.014. Epub 2012 Oct 22. PMID: 23085193; PMCID: PMC3732748.

Suliman MA, Khalil FM, Alkindi SS, Pathare AV, Almadhani AA, Soliman NA. Tumor necrosis factor-α and interleukin-6 in cirrhotic patients with spontaneous bacterial peritonitis. World J Gastrointest Pathophysiol. 2012 Oct 15;3(5):92-8. doi: 10.4291/wjgp.v3.i5.92. PMID: 23515243; PMCID: PMC3602440.

How to Cite
Mammadova, E. T. (2020). Levels of cytokines in extended purulent peritonitis and methods of immunocorrection. Klinicheskaia Khirurgiia, 87(11-12), 54-61. https://doi.org/10.26779/2522-1396.2020.11-12.54
General Problems of Surgery